Literature DB >> 11544099

The role of the activin-follistatin system in the developmental and regeneration processes of the kidney.

A Maeshima1, Y Nojima, I Kojima.   

Abstract

Regeneration processes in many tissues are modulated by various factors, which are involved in their organogenesis. Activin A, a member of the TGF-beta superfamily, inhibits branching tubulogenesis of the kidney in organ culture system as well as in in vitro tubulogenesis model. On the other hand, follistatin, an antagonist activin A, reverses the effect of activin A on kidney development, induces branching tubulogenesis, and also promotes tubular regeneration after ischemia/reperfusion injury by blocking the action of endogenous activin A. The activin-follistatin system is one of the important regulatory systems modulating developmental and regeneration processes of the kidneys.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544099     DOI: 10.1016/s1359-6101(01)00010-7

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  19 in total

1.  Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice.

Authors:  Andrew I Su; Luca G Guidotti; John Paul Pezacki; Francis V Chisari; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

2.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

3.  Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.

Authors:  Anders Nordholm; Maria L Mace; Eva Gravesen; Jacob Hofman-Bang; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

4.  Recapitulating kidney development in vitro by priming and differentiating mouse embryonic stem cells in monolayers.

Authors:  Theresa Chow; Frances T M Wong; Claudio Monetti; Andras Nagy; Brian Cox; Ian M Rogers
Journal:  NPJ Regen Med       Date:  2020-04-20

5.  Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.

Authors:  Olga A Agapova; Yifu Fang; Toshifumi Sugatani; Michael E Seifert; Keith A Hruska
Journal:  Kidney Int       Date:  2016-03-11       Impact factor: 10.612

Review 6.  Phylogenetic, ontogenetic, and pathological aspects of the urine-concentrating mechanism.

Authors:  Yoshiaki Kondo; Tetsuji Morimoto; Toshiyuki Nishio; Ulviyya Fizuli Aslanova; Minako Nishino; Elnur Ilham Farajov; Noriko Sugawara; Naonori Kumagai; Atsushi Ohsaga; Yoshio Maruyama; Shori Takahashi
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

Review 7.  The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.

Authors:  Keith A Hruska; Toshifumi Sugatani; Olga Agapova; Yifu Fang
Journal:  Bone       Date:  2017-01-22       Impact factor: 4.398

Review 8.  Pathophysiology of the chronic kidney disease-mineral bone disorder.

Authors:  Keith A Hruska; Michael Seifert; Toshifumi Sugatani
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

Review 9.  Label-retaining cells in the kidney: origin of regenerating cells after renal ischemia.

Authors:  Akito Maeshima
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

Review 10.  Transforming growth factor beta signaling functions during mammalian kidney development.

Authors:  Mihai G Dumbrava; Jon L Lacanlale; Christopher J Rowan; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2020-09-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.